Exact Mass: 275.127

Exact Mass Matches: 275.127

Found 94 metabolites which its exact mass value is equals to given mass value 275.127, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tryptophyl-Alanine

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}propanoate

C14H17N3O3 (275.127)


Tryptophyl-Alanine is a dipeptide composed of tryptophan and alanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Glutarylcarnitine (C5-DC)

(3R)-3-[(4-carboxybutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C12H21NO6 (275.1369)


Glutarylcarnitine is an acylcarnitine. More specifically, it is an glutaric acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Glutarylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine glutarylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). Glutarylcarnitine has been identified in the human placenta (PMID: 32033212 ). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. Glutarylcarnitine is the diagnostic metabolite for malonic aciduria and glutaric aciduria type I monitored in most tandem mass spectrometry newborn screening programmes.

   

Alanyltryptophan

(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanoic acid

C14H17N3O3 (275.127)


Alanyltryptophan is a dipeptide composed of alanine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

O-Glutarylcarnitine

3-[(4-Carboxybutanoyl)oxy]-4-(trimethylammonio)butanoic acid

C12H21NO6 (275.1369)


O-Glutarylcarnitine is an acylcarnitine. More specifically, it is an glutaric acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. O-Glutarylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine O-Glutarylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2-Ethylpropanedioylcarnitine

3-[(2-carboxy-2-ethylacetyl)oxy]-4-(trimethylazaniumyl)butanoate

C12H21NO6 (275.1369)


2-Ethylpropanedioylcarnitine is an acylcarnitine. More specifically, it is an 2-ethylpropanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Ethylpropanedioylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine 2-Ethylpropanedioylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Imazapic

Imazapic

C14H17N3O3 (275.127)


D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3452; ORIGINAL_PRECURSOR_SCAN_NO 3451 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3472; ORIGINAL_PRECURSOR_SCAN_NO 3470 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3387; ORIGINAL_PRECURSOR_SCAN_NO 3385 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3462; ORIGINAL_PRECURSOR_SCAN_NO 3461 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3400; ORIGINAL_PRECURSOR_SCAN_NO 3398 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3396; ORIGINAL_PRECURSOR_SCAN_NO 3394 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7071; ORIGINAL_PRECURSOR_SCAN_NO 7067 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7108; ORIGINAL_PRECURSOR_SCAN_NO 7106 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7114; ORIGINAL_PRECURSOR_SCAN_NO 7111 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7134; ORIGINAL_PRECURSOR_SCAN_NO 7132 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7141; ORIGINAL_PRECURSOR_SCAN_NO 7139 CONFIDENCE standard compound; INTERNAL_ID 616; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7149; ORIGINAL_PRECURSOR_SCAN_NO 7147

   

N1-(2,4-Dimethoxyphenyl)-2-cyano-3-(dimethylamino)acrylamide

N1-(2,4-Dimethoxyphenyl)-2-cyano-3-(dimethylamino)acrylamide

C14H17N3O3 (275.127)


   
   

triethyl 1-aminopropane-1,2,3-tricarboxylate

triethyl 1-aminopropane-1,2,3-tricarboxylate

C12H21NO6 (275.1369)


   

(2E,4E,6E)-N-isopentyl-7-(2-thienyl)-2,4,6-heptatrienamide

(2E,4E,6E)-N-isopentyl-7-(2-thienyl)-2,4,6-heptatrienamide

C16H21NOS (275.1344)


   
   

alanyltryptophan

alanyltryptophan

C14H17N3O3 (275.127)


Alanyltryptophan is a derivative of tryptophan. Tryptophan is an essential amino acid which is the precursor of serotonin. [HMDB]

   

Glutaryl-carnitine; AIF; CE00; CorrDec

Glutaryl-carnitine; AIF; CE00; CorrDec

C12H21NO6 (275.1369)


   

Glutaryl-carnitine; AIF; CE10; CorrDec

Glutaryl-carnitine; AIF; CE10; CorrDec

C12H21NO6 (275.1369)


   

Glutaryl-carnitine; AIF; CE30; CorrDec

Glutaryl-carnitine; AIF; CE30; CorrDec

C12H21NO6 (275.1369)


   

Glutaryl-carnitine; AIF; CE0; MS2Dec

Glutaryl-carnitine; AIF; CE0; MS2Dec

C12H21NO6 (275.1369)


   

Glutaryl-carnitine; AIF; CE10; MS2Dec

Glutaryl-carnitine; AIF; CE10; MS2Dec

C12H21NO6 (275.1369)


   

Glutaryl-carnitine; AIF; CE30; MS2Dec

Glutaryl-carnitine; AIF; CE30; MS2Dec

C12H21NO6 (275.1369)


   

Glutarylcarnitine

Glutarylcarnitine

C12H21NO6 (275.1369)


Glutarylcarnitine is the diagnostic metabolite for malonic aciduria and glutaric aciduria type I monitored in most tandem mass spectrometry newborn screening programmes.

   

O4-Pyridylhydroxybutyl-thymine

O4-Pyridylhydroxybutyl-thymine

C14H17N3O3 (275.127)


   

3-Pyridylhydroxybutyl-thymine

3-Pyridylhydroxybutyl-thymine

C14H17N3O3 (275.127)


   

O2-Pyridylhydroxybutyl-thymine

O2-Pyridylhydroxybutyl-thymine

C14H17N3O3 (275.127)


   
   
   

Ala-Trp

2-[2-amino-3-(1H-indol-3-yl)propanamido]propanoic acid

C14H17N3O3 (275.127)


A dipeptide formed from L-alanyl and L-tryptophan residues.

   

TRP-Ala

2-(2-aminopropanamido)-3-(1H-indol-3-yl)propanoic acid

C14H17N3O3 (275.127)


A dipeptide formed from L-tryptophan and L-alanine residues.

   

CAR 5:1;O2

3-[(4-carboxybutanoyl)oxy]-4-(trimethylammonio)butanoate;glutarylcarnitine

C12H21NO6 (275.1369)


   

[7-methyl-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

[7-methyl-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

C14H18BNO4 (275.1329)


   

[4-(Diphenylamino)phenyl]methanol

[4-(Diphenylamino)phenyl]methanol

C19H17NO (275.131)


   

Tetraethylammonium hexafluorophosphate

Tetraethylammonium hexafluorophosphate

C8H20F6NP (275.1237)


   

METHYL 2-OXO-1-(PIPERIDIN-4-YL)-2,3-DIHYDRO-1H-BENZO[D]IMIDAZOLE-5-CARBOXYLATE

METHYL 2-OXO-1-(PIPERIDIN-4-YL)-2,3-DIHYDRO-1H-BENZO[D]IMIDAZOLE-5-CARBOXYLATE

C14H17N3O3 (275.127)


   

3-nitro-trans-beta-styrylboronic acid pinacol ester

3-nitro-trans-beta-styrylboronic acid pinacol ester

C14H18BNO4 (275.1329)


   

Ethanol,2,2,2-nitrilotris-, 1,1,1-triacetate

Ethanol,2,2,2-nitrilotris-, 1,1,1-triacetate

C12H21NO6 (275.1369)


   

N-BOC-THIOMORPHOLINE-3-CARBOXYLIC ACID ETHYL ESTER

N-BOC-THIOMORPHOLINE-3-CARBOXYLIC ACID ETHYL ESTER

C12H21NO4S (275.1191)


   

Boc-Glu(Ome)-OMe

Boc-Glu(Ome)-OMe

C12H21NO6 (275.1369)


   

4-(4-METHOXY-2,5-DIMETHYL-PHENYL)-5-METHYL-THIAZOL-2-YLAMINE

4-(4-METHOXY-2,5-DIMETHYL-PHENYL)-5-METHYL-THIAZOL-2-YLAMINE

C14H17N3O3 (275.127)


   

3-hydroxy-N-(1-methylpyrazol-3-yl)-5-propan-2-yloxybenzamide

3-hydroxy-N-(1-methylpyrazol-3-yl)-5-propan-2-yloxybenzamide

C14H17N3O3 (275.127)


   

GR 135531

5-Methoxycarbonylamino-N-acetyltryptamine

C14H17N3O3 (275.127)


   

(2,4-DIMETHOXY-BENZYL)-(4-FLUORO-BENZYL)-AMINE

(2,4-DIMETHOXY-BENZYL)-(4-FLUORO-BENZYL)-AMINE

C16H18FNO2 (275.1322)


   

7-Diethylamino-2-Oxo-Chromene-3-Carbohydrazide

7-Diethylamino-2-Oxo-Chromene-3-Carbohydrazide

C14H17N3O3 (275.127)


   

4,4,5,5-tetramethyl-2-[(E)-2-(4-nitrophenyl)ethenyl]-1,3,2-dioxaborolane

4,4,5,5-tetramethyl-2-[(E)-2-(4-nitrophenyl)ethenyl]-1,3,2-dioxaborolane

C14H18BNO4 (275.1329)


   

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one

C14H18BNO4 (275.1329)


   

Trisguanidinium phosphate

Trisguanidinium phosphate

C3H18N9O4P (275.1219)


   

(2S,4R)-N-Boc-4-acetylthio-2-hydroxymethyl-1-pyrrolidinecarboxylic acid

(2S,4R)-N-Boc-4-acetylthio-2-hydroxymethyl-1-pyrrolidinecarboxylic acid

C12H21NO4S (275.1191)


   

3-(4-BENZYL-PHENOXY)-PHENYLAMINE

3-(4-BENZYL-PHENOXY)-PHENYLAMINE

C19H17NO (275.131)


   

2H-Thiopyran-4-acetic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]tetrahydro

2H-Thiopyran-4-acetic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]tetrahydro

C12H21NO4S (275.1191)


   

4-Methoxytriphenylamine

4-Methoxytriphenylamine

C19H17NO (275.131)


   

O-Tritylhydroxylamine

O-Tritylhydroxylamine

C19H17NO (275.131)


   

1-Pyrrolidinecarboxylic acid, 4-(acetylthio)-2-(hydroxymethyl)-, 1,1-dimethylethyl ester, (2S,4S)

1-Pyrrolidinecarboxylic acid, 4-(acetylthio)-2-(hydroxymethyl)-, 1,1-dimethylethyl ester, (2S,4S)

C12H21NO4S (275.1191)


   

(1-(TERT-BUTOXYCARBONYL)-4-METHYL-1H-INDOL-2-YL)BORONIC ACID

(1-(TERT-BUTOXYCARBONYL)-4-METHYL-1H-INDOL-2-YL)BORONIC ACID

C14H18BNO4 (275.1329)


   

Spiro[piperidine-4,2(3aH)-thiazolo[5,4-c]pyridine],4,5,6,7-tetrahydro-1,5-dimethyl-, hydrochloride (1:2)

Spiro[piperidine-4,2(3aH)-thiazolo[5,4-c]pyridine],4,5,6,7-tetrahydro-1,5-dimethyl-, hydrochloride (1:2)

C12H22ClN3S (275.1223)


   

3-methoxy-N,N-diphenylaniline

3-methoxy-N,N-diphenylaniline

C19H17NO (275.131)


   

Choline tosylate

Choline tosylate

C12H21NO4S (275.1191)


Choline tosylate is a nucleophilic compound that inhibits phospholipase A2 and phospholipase C. Choline tosylate inhibits tumor growth in mice by inhibiting the formation of diacylglycerol (DAG)[1][2].

   

Ethyl N-Boc-2-thiomorpholinecarboxylate

Ethyl N-Boc-2-thiomorpholinecarboxylate

C12H21NO4S (275.1191)


   

2-(1,2,3,4-TETRAHYDROISOQUINOLIN-1-YL)-1-NAPHTHOL

2-(1,2,3,4-TETRAHYDROISOQUINOLIN-1-YL)-1-NAPHTHOL

C19H17NO (275.131)


   

Levalbuterol Hydrochloride

Levalbuterol Hydrochloride

C13H22ClNO3 (275.1288)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist Levalbuterol ((R)-Albuterol) hydrochloride is a short-acting β2-adrenergic receptor agonist and the active (R)-enantiomer of Salbutamol. Levalbuterol hydrochloride is a more potent bronchodilator than Salbutamol and has the potential for the treatment of COPD[1].

   

4-CYANO-3-FLUOROPHENYL TRANS-4-ETHYLCYCLOHEXANECARBOXYLATE

4-CYANO-3-FLUOROPHENYL TRANS-4-ETHYLCYCLOHEXANECARBOXYLATE

C16H18FNO2 (275.1322)


   

ethyl 3-[ethoxycarbonyl-(2-ethoxy-2-oxoethyl)amino]propanoate

ethyl 3-[ethoxycarbonyl-(2-ethoxy-2-oxoethyl)amino]propanoate

C12H21NO6 (275.1369)


   

1-Boc-5-Methyl-1H-indole-2-boronic acid

1-Boc-5-Methyl-1H-indole-2-boronic acid

C14H18BNO4 (275.1329)


   

1-BOC-6-methylindole-2-boronic acid

1-BOC-6-methylindole-2-boronic acid

C14H18BNO4 (275.1329)


   

4-(5-cyanopyridin-2-yl)-n-methyl-1,4-diazepane-1-carbothioamide

4-(5-cyanopyridin-2-yl)-n-methyl-1,4-diazepane-1-carbothioamide

C13H17N5S (275.1205)


   

(2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide

(2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide

C14H17N3O3 (275.127)


   

7-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE

7-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE

C14H18BNO4 (275.1329)


   

ethyl 3-amino-1-[(4-methoxyphenyl)methyl]pyrazole-4-carboxylate

ethyl 3-amino-1-[(4-methoxyphenyl)methyl]pyrazole-4-carboxylate

C14H17N3O3 (275.127)


   

6-[4-(DIMETHYLAMINO)PHENYL]-1,2,5,6-TETRAHYDRO-4-METHYL-2-OXO-5-PYRIMIDINECARBOX

6-[4-(DIMETHYLAMINO)PHENYL]-1,2,5,6-TETRAHYDRO-4-METHYL-2-OXO-5-PYRIMIDINECARBOX

C14H17N3O3 (275.127)


   

DIETHYL2-(TERT-BUTOXYCARBONYLAMINO)MALONATE

DIETHYL2-(TERT-BUTOXYCARBONYLAMINO)MALONATE

C12H21NO6 (275.1369)


   

Omigapil

Omigapil

C19H17NO (275.131)


C471 - Enzyme Inhibitor

   

Isoetharine hydrochloride

Isoetharine hydrochloride

C13H22ClNO3 (275.1288)


   

Benzo[a]phenoxazin-9-ylidene(dimethyl)azanium

Benzo[a]phenoxazin-9-ylidene(dimethyl)azanium

C18H15N2O+ (275.1184)


   

5-Methyl-2-((4R)-4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl) nicotinic acid

5-Methyl-2-((4R)-4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl) nicotinic acid

C14H17N3O3 (275.127)


   

5-Methyl-2-((4S)-4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl) nicotinic acid

5-Methyl-2-((4S)-4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl) nicotinic acid

C14H17N3O3 (275.127)


   

3-(Naphthalen-1-ylmethyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine

3-(Naphthalen-1-ylmethyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine

C16H13N5 (275.1171)


   

1-Methyl-3-Naphthalen-2-Yl-1h-Pyrazolo[3,4-D]pyrimidin-4-Amine

1-Methyl-3-Naphthalen-2-Yl-1h-Pyrazolo[3,4-D]pyrimidin-4-Amine

C16H13N5 (275.1171)


   

(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one

(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one

C13H14FN5O (275.1182)


   

L-saccharopinate(1-)

L-saccharopinate(1-)

C11H19N2O6- (275.1243)


The conjugate base of L-saccharopine arising from deprotonation of all three carboxy groups and protonation of the primary and secondary amino groups; major species at pH 7.3.

   

2-Ethylpropanedioylcarnitine

2-Ethylpropanedioylcarnitine

C12H21NO6 (275.1369)


   

1-[2-(4-Methoxyphenyl)ethyl]-3,5-dimethyl-4-nitropyrazole

1-[2-(4-Methoxyphenyl)ethyl]-3,5-dimethyl-4-nitropyrazole

C14H17N3O3 (275.127)


   

(E)-N-[2-(1-methyltetrazol-5-yl)sulfanylethyl]-3-phenylprop-2-en-1-amine

(E)-N-[2-(1-methyltetrazol-5-yl)sulfanylethyl]-3-phenylprop-2-en-1-amine

C13H17N5S (275.1205)


   

2-(Hydroxymethyl)-3-(5-nitro-2-pyrrolidin-1-ylphenyl)propanenitrile

2-(Hydroxymethyl)-3-(5-nitro-2-pyrrolidin-1-ylphenyl)propanenitrile

C14H17N3O3 (275.127)


   

5-(6-Aminohexanamido)isatin

5-(6-Aminohexanamido)isatin

C14H17N3O3 (275.127)


   

(3R)-3-(4-carboxybutanoyloxy)-4-[methyl-bis(trideuteriomethyl)azaniumyl]butanoate

(3R)-3-(4-carboxybutanoyloxy)-4-[methyl-bis(trideuteriomethyl)azaniumyl]butanoate

C12H21NO6 (275.1369)


   

H-Ala-Trp-OH

L-Alanyl-L-tryptophan

C14H17N3O3 (275.127)


   

O-glutarylcarnitine

O-glutarylcarnitine

C12H21NO6 (275.1369)


An O-acylcarnitine having glutaryl as the acyl substituent.

   

(3S)-3-[(4-carboxybutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

(3S)-3-[(4-carboxybutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C12H21NO6 (275.1369)


   

O-Glutaroyl-L-carnitine

O-Glutaroyl-L-carnitine

C12H21NO6 (275.1369)


An O-acyl-L-carnitine in which the acyl group is specified as glutaroyl.

   
   

Cyclo(Gln-Phe)

Cyclo(Gln-Phe)

C14H17N3O3 (275.127)


   

(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-(1h-indol-3-yl)propanoic acid

(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-(1h-indol-3-yl)propanoic acid

C14H17N3O3 (275.127)


   

3-[(2s,5s)-5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]propanimidic acid

3-[(2s,5s)-5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]propanimidic acid

C14H17N3O3 (275.127)


   

(2e,4e,6e)-n-(3-methylbutyl)-7-(thiophen-2-yl)hepta-2,4,6-trienimidic acid

(2e,4e,6e)-n-(3-methylbutyl)-7-(thiophen-2-yl)hepta-2,4,6-trienimidic acid

C16H21NOS (275.1344)


   

13-hydroxy-4-imino-6,11,11-trimethyl-9-oxa-3,5-diazatricyclo[8.4.0.0²,⁷]tetradeca-1(10),2,6-trien-8-one

13-hydroxy-4-imino-6,11,11-trimethyl-9-oxa-3,5-diazatricyclo[8.4.0.0²,⁷]tetradeca-1(10),2,6-trien-8-one

C14H17N3O3 (275.127)


   

(13r)-13-hydroxy-4-imino-6,11,11-trimethyl-9-oxa-3,5-diazatricyclo[8.4.0.0²,⁷]tetradeca-1(10),2,6-trien-8-one

(13r)-13-hydroxy-4-imino-6,11,11-trimethyl-9-oxa-3,5-diazatricyclo[8.4.0.0²,⁷]tetradeca-1(10),2,6-trien-8-one

C14H17N3O3 (275.127)


   

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(1h-indol-3-yl)propylidene]amino}propanoic acid

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(1h-indol-3-yl)propylidene]amino}propanoic acid

C14H17N3O3 (275.127)